nodes	percent_of_prediction	percent_of_DWPC	metapath
Decitabine—DNMT3A—Amcinonide—Betamethasone—ankylosing spondylitis	0.00518	0.066	CbGdCrCtD
Decitabine—DNMT3A—Amcinonide—Dexamethasone—ankylosing spondylitis	0.00518	0.066	CbGdCrCtD
Decitabine—DNMT3A—Amcinonide—Triamcinolone—ankylosing spondylitis	0.00506	0.0645	CbGdCrCtD
Decitabine—DNMT3A—Amcinonide—Prednisone—ankylosing spondylitis	0.0048	0.0612	CbGdCrCtD
Decitabine—DNMT3A—Amcinonide—Prednisolone—ankylosing spondylitis	0.00468	0.0598	CbGdCrCtD
Decitabine—DNMT1—Budesonide—Methylprednisolone—ankylosing spondylitis	0.00208	0.0265	CbGdCrCtD
Decitabine—DNMT1—Budesonide—Dexamethasone—ankylosing spondylitis	0.00205	0.0261	CbGdCrCtD
Decitabine—DNMT1—Budesonide—Betamethasone—ankylosing spondylitis	0.00205	0.0261	CbGdCrCtD
Decitabine—DNMT1—Budesonide—Triamcinolone—ankylosing spondylitis	0.002	0.0255	CbGdCrCtD
Decitabine—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00192	0.00209	CcSEcCtD
Decitabine—Cough—Triamcinolone—ankylosing spondylitis	0.00191	0.00207	CcSEcCtD
Decitabine—DNMT1—Budesonide—Prednisone—ankylosing spondylitis	0.0019	0.0242	CbGdCrCtD
Decitabine—Tachycardia—Prednisolone—ankylosing spondylitis	0.00189	0.00205	CcSEcCtD
Decitabine—Hypertension—Triamcinolone—ankylosing spondylitis	0.00189	0.00205	CcSEcCtD
Decitabine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00188	0.00204	CcSEcCtD
Decitabine—Myalgia—Triamcinolone—ankylosing spondylitis	0.00186	0.00202	CcSEcCtD
Decitabine—Pneumonia—Methotrexate—ankylosing spondylitis	0.00186	0.00202	CcSEcCtD
Decitabine—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00186	0.00201	CcSEcCtD
Decitabine—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00186	0.00201	CcSEcCtD
Decitabine—Eye disorder—Prednisone—ankylosing spondylitis	0.00185	0.00201	CcSEcCtD
Decitabine—DNMT1—Budesonide—Prednisolone—ankylosing spondylitis	0.00185	0.0236	CbGdCrCtD
Decitabine—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00185	0.00201	CcSEcCtD
Decitabine—Infestation—Methotrexate—ankylosing spondylitis	0.00185	0.002	CcSEcCtD
Decitabine—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00185	0.002	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00184	0.002	CcSEcCtD
Decitabine—Depression—Methotrexate—ankylosing spondylitis	0.00184	0.002	CcSEcCtD
Decitabine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00184	0.002	CcSEcCtD
Decitabine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00184	0.002	CcSEcCtD
Decitabine—Discomfort—Triamcinolone—ankylosing spondylitis	0.00184	0.00199	CcSEcCtD
Decitabine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00183	0.00199	CcSEcCtD
Decitabine—Renal failure—Methotrexate—ankylosing spondylitis	0.00182	0.00197	CcSEcCtD
Decitabine—Stomatitis—Methotrexate—ankylosing spondylitis	0.0018	0.00195	CcSEcCtD
Decitabine—Angiopathy—Prednisone—ankylosing spondylitis	0.0018	0.00195	CcSEcCtD
Decitabine—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00179	0.00195	CcSEcCtD
Decitabine—Immune system disorder—Prednisone—ankylosing spondylitis	0.00179	0.00194	CcSEcCtD
Decitabine—Malaise—Betamethasone—ankylosing spondylitis	0.00179	0.00194	CcSEcCtD
Decitabine—Malaise—Dexamethasone—ankylosing spondylitis	0.00179	0.00194	CcSEcCtD
Decitabine—Oedema—Triamcinolone—ankylosing spondylitis	0.00178	0.00194	CcSEcCtD
Decitabine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00178	0.00194	CcSEcCtD
Decitabine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00178	0.00193	CcSEcCtD
Decitabine—Infection—Triamcinolone—ankylosing spondylitis	0.00177	0.00192	CcSEcCtD
Decitabine—Infection—Methylprednisolone—ankylosing spondylitis	0.00177	0.00192	CcSEcCtD
Decitabine—Insomnia—Prednisolone—ankylosing spondylitis	0.00175	0.0019	CcSEcCtD
Decitabine—Alopecia—Prednisone—ankylosing spondylitis	0.00175	0.0019	CcSEcCtD
Decitabine—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00175	0.00189	CcSEcCtD
Decitabine—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00175	0.00189	CcSEcCtD
Decitabine—Epistaxis—Methotrexate—ankylosing spondylitis	0.00174	0.00189	CcSEcCtD
Decitabine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00174	0.00189	CcSEcCtD
Decitabine—Mental disorder—Prednisone—ankylosing spondylitis	0.00174	0.00189	CcSEcCtD
Decitabine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00174	0.00188	CcSEcCtD
Decitabine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00173	0.00188	CcSEcCtD
Decitabine—Erythema—Prednisone—ankylosing spondylitis	0.00173	0.00187	CcSEcCtD
Decitabine—Malnutrition—Prednisone—ankylosing spondylitis	0.00173	0.00187	CcSEcCtD
Decitabine—Hypertension—Betamethasone—ankylosing spondylitis	0.00171	0.00186	CcSEcCtD
Decitabine—Hypertension—Dexamethasone—ankylosing spondylitis	0.00171	0.00186	CcSEcCtD
Decitabine—Myalgia—Dexamethasone—ankylosing spondylitis	0.00169	0.00183	CcSEcCtD
Decitabine—Myalgia—Betamethasone—ankylosing spondylitis	0.00169	0.00183	CcSEcCtD
Decitabine—Anxiety—Dexamethasone—ankylosing spondylitis	0.00168	0.00183	CcSEcCtD
Decitabine—Anxiety—Betamethasone—ankylosing spondylitis	0.00168	0.00183	CcSEcCtD
Decitabine—DNMT3A—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.00168	0.0214	CbGdCrCtD
Decitabine—DNMT3A—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.00168	0.0214	CbGdCrCtD
Decitabine—Discomfort—Dexamethasone—ankylosing spondylitis	0.00167	0.00181	CcSEcCtD
Decitabine—Discomfort—Betamethasone—ankylosing spondylitis	0.00167	0.00181	CcSEcCtD
Decitabine—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00167	0.00181	CcSEcCtD
Decitabine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00166	0.0018	CcSEcCtD
Decitabine—Pain—Prednisolone—ankylosing spondylitis	0.00166	0.0018	CcSEcCtD
Decitabine—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00166	0.0018	CcSEcCtD
Decitabine—DNMT3A—Betamethasone—Dexamethasone—ankylosing spondylitis	0.00165	0.0211	CbGdCrCtD
Decitabine—DNMT3A—Dexamethasone—Betamethasone—ankylosing spondylitis	0.00165	0.0211	CbGdCrCtD
Decitabine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00165	0.00179	CcSEcCtD
Decitabine—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00164	0.00178	CcSEcCtD
Decitabine—Vision blurred—Prednisone—ankylosing spondylitis	0.00163	0.00177	CcSEcCtD
Decitabine—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00162	0.00176	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00162	0.00176	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00162	0.00176	CcSEcCtD
Decitabine—Oedema—Dexamethasone—ankylosing spondylitis	0.00162	0.00176	CcSEcCtD
Decitabine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00162	0.00176	CcSEcCtD
Decitabine—Oedema—Betamethasone—ankylosing spondylitis	0.00162	0.00176	CcSEcCtD
Decitabine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00162	0.00176	CcSEcCtD
Decitabine—DNMT3A—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.00161	0.0206	CbGdCrCtD
Decitabine—DNMT3A—Betamethasone—Triamcinolone—ankylosing spondylitis	0.00161	0.0206	CbGdCrCtD
Decitabine—Insomnia—Triamcinolone—ankylosing spondylitis	0.00161	0.00175	CcSEcCtD
Decitabine—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00161	0.00175	CcSEcCtD
Decitabine—Infection—Dexamethasone—ankylosing spondylitis	0.00161	0.00174	CcSEcCtD
Decitabine—Infection—Betamethasone—ankylosing spondylitis	0.00161	0.00174	CcSEcCtD
Decitabine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.0016	0.00174	CcSEcCtD
Decitabine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.0016	0.00173	CcSEcCtD
Decitabine—Anaemia—Prednisone—ankylosing spondylitis	0.0016	0.00173	CcSEcCtD
Decitabine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00159	0.00173	CcSEcCtD
Decitabine—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00159	0.00172	CcSEcCtD
Decitabine—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00159	0.00172	CcSEcCtD
Decitabine—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00158	0.00172	CcSEcCtD
Decitabine—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00158	0.00172	CcSEcCtD
Decitabine—Tachycardia—Betamethasone—ankylosing spondylitis	0.00158	0.00171	CcSEcCtD
Decitabine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00158	0.00171	CcSEcCtD
Decitabine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00157	0.0017	CcSEcCtD
Decitabine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00157	0.0017	CcSEcCtD
Decitabine—Malaise—Prednisone—ankylosing spondylitis	0.00156	0.00169	CcSEcCtD
Decitabine—Eye disorder—Methotrexate—ankylosing spondylitis	0.00155	0.00168	CcSEcCtD
Decitabine—Anorexia—Betamethasone—ankylosing spondylitis	0.00154	0.00167	CcSEcCtD
Decitabine—Anorexia—Dexamethasone—ankylosing spondylitis	0.00154	0.00167	CcSEcCtD
Decitabine—Urticaria—Prednisolone—ankylosing spondylitis	0.00154	0.00167	CcSEcCtD
Decitabine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00154	0.00167	CcSEcCtD
Decitabine—Fatigue—Triamcinolone—ankylosing spondylitis	0.00154	0.00167	CcSEcCtD
Decitabine—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00153	0.00166	CcSEcCtD
Decitabine—DNMT3A—Betamethasone—Prednisone—ankylosing spondylitis	0.00153	0.0195	CbGdCrCtD
Decitabine—DNMT3A—Dexamethasone—Prednisone—ankylosing spondylitis	0.00153	0.0195	CbGdCrCtD
Decitabine—Pain—Triamcinolone—ankylosing spondylitis	0.00153	0.00165	CcSEcCtD
Decitabine—Hypotension—Betamethasone—ankylosing spondylitis	0.00151	0.00164	CcSEcCtD
Decitabine—Hypotension—Dexamethasone—ankylosing spondylitis	0.00151	0.00164	CcSEcCtD
Decitabine—Angiopathy—Methotrexate—ankylosing spondylitis	0.0015	0.00163	CcSEcCtD
Decitabine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.0015	0.00162	CcSEcCtD
Decitabine—DNMT3A—Betamethasone—Prednisolone—ankylosing spondylitis	0.00149	0.0191	CbGdCrCtD
Decitabine—DNMT3A—Dexamethasone—Prednisolone—ankylosing spondylitis	0.00149	0.0191	CbGdCrCtD
Decitabine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00149	0.00162	CcSEcCtD
Decitabine—Hypertension—Prednisone—ankylosing spondylitis	0.00149	0.00162	CcSEcCtD
Decitabine—Chills—Methotrexate—ankylosing spondylitis	0.00149	0.00161	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00147	0.0016	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00147	0.0016	CcSEcCtD
Decitabine—Myalgia—Prednisone—ankylosing spondylitis	0.00147	0.0016	CcSEcCtD
Decitabine—Arthralgia—Prednisone—ankylosing spondylitis	0.00147	0.0016	CcSEcCtD
Decitabine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00147	0.00159	CcSEcCtD
Decitabine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00147	0.00159	CcSEcCtD
Decitabine—Anxiety—Prednisone—ankylosing spondylitis	0.00146	0.00159	CcSEcCtD
Decitabine—Alopecia—Methotrexate—ankylosing spondylitis	0.00146	0.00159	CcSEcCtD
Decitabine—Insomnia—Dexamethasone—ankylosing spondylitis	0.00146	0.00159	CcSEcCtD
Decitabine—Insomnia—Betamethasone—ankylosing spondylitis	0.00146	0.00159	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00146	0.00158	CcSEcCtD
Decitabine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00146	0.00158	CcSEcCtD
Decitabine—Discomfort—Prednisone—ankylosing spondylitis	0.00145	0.00158	CcSEcCtD
Decitabine—Mental disorder—Methotrexate—ankylosing spondylitis	0.00145	0.00158	CcSEcCtD
Decitabine—Malnutrition—Methotrexate—ankylosing spondylitis	0.00144	0.00157	CcSEcCtD
Decitabine—Erythema—Methotrexate—ankylosing spondylitis	0.00144	0.00157	CcSEcCtD
Decitabine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00143	0.00155	CcSEcCtD
Decitabine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00142	0.00155	CcSEcCtD
Decitabine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00142	0.00155	CcSEcCtD
Decitabine—Urticaria—Triamcinolone—ankylosing spondylitis	0.00142	0.00154	CcSEcCtD
Decitabine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00141	0.00153	CcSEcCtD
Decitabine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00141	0.00153	CcSEcCtD
Decitabine—Oedema—Prednisone—ankylosing spondylitis	0.00141	0.00153	CcSEcCtD
Decitabine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00141	0.00153	CcSEcCtD
Decitabine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00141	0.00153	CcSEcCtD
Decitabine—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00141	0.00153	CcSEcCtD
Decitabine—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00141	0.00153	CcSEcCtD
Decitabine—Infection—Prednisone—ankylosing spondylitis	0.0014	0.00152	CcSEcCtD
Decitabine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.0014	0.00152	CcSEcCtD
Decitabine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.0014	0.00152	CcSEcCtD
Decitabine—Back pain—Methotrexate—ankylosing spondylitis	0.0014	0.00151	CcSEcCtD
Decitabine—Fatigue—Dexamethasone—ankylosing spondylitis	0.0014	0.00151	CcSEcCtD
Decitabine—Fatigue—Betamethasone—ankylosing spondylitis	0.0014	0.00151	CcSEcCtD
Decitabine—Pain—Betamethasone—ankylosing spondylitis	0.00138	0.0015	CcSEcCtD
Decitabine—Pain—Dexamethasone—ankylosing spondylitis	0.00138	0.0015	CcSEcCtD
Decitabine—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00138	0.0015	CcSEcCtD
Decitabine—Tachycardia—Prednisone—ankylosing spondylitis	0.00138	0.00149	CcSEcCtD
Decitabine—Skin disorder—Prednisone—ankylosing spondylitis	0.00137	0.00149	CcSEcCtD
Decitabine—Vision blurred—Methotrexate—ankylosing spondylitis	0.00136	0.00148	CcSEcCtD
Decitabine—Anorexia—Prednisone—ankylosing spondylitis	0.00134	0.00146	CcSEcCtD
Decitabine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00134	0.00145	CcSEcCtD
Decitabine—Anaemia—Methotrexate—ankylosing spondylitis	0.00133	0.00145	CcSEcCtD
Decitabine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00133	0.00145	CcSEcCtD
Decitabine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00133	0.00145	CcSEcCtD
Decitabine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00132	0.00144	CcSEcCtD
Decitabine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00132	0.00144	CcSEcCtD
Decitabine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00131	0.00143	CcSEcCtD
Decitabine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00131	0.00142	CcSEcCtD
Decitabine—Malaise—Methotrexate—ankylosing spondylitis	0.0013	0.00141	CcSEcCtD
Decitabine—Leukopenia—Methotrexate—ankylosing spondylitis	0.00129	0.0014	CcSEcCtD
Decitabine—Urticaria—Betamethasone—ankylosing spondylitis	0.00129	0.00139	CcSEcCtD
Decitabine—Urticaria—Dexamethasone—ankylosing spondylitis	0.00129	0.00139	CcSEcCtD
Decitabine—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00128	0.00139	CcSEcCtD
Decitabine—Dizziness—Prednisolone—ankylosing spondylitis	0.00128	0.00139	CcSEcCtD
Decitabine—Asthenia—Triamcinolone—ankylosing spondylitis	0.00128	0.00139	CcSEcCtD
Decitabine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00128	0.00139	CcSEcCtD
Decitabine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00128	0.00139	CcSEcCtD
Decitabine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00128	0.00139	CcSEcCtD
Decitabine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00128	0.00139	CcSEcCtD
Decitabine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00128	0.00139	CcSEcCtD
Decitabine—Insomnia—Prednisone—ankylosing spondylitis	0.00127	0.00138	CcSEcCtD
Decitabine—DNMT1—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.00127	0.0162	CbGdCrCtD
Decitabine—DNMT1—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.00127	0.0162	CbGdCrCtD
Decitabine—Pruritus—Triamcinolone—ankylosing spondylitis	0.00126	0.00137	CcSEcCtD
Decitabine—Cough—Methotrexate—ankylosing spondylitis	0.00126	0.00137	CcSEcCtD
Decitabine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00126	0.00137	CcSEcCtD
Decitabine—DNMT1—Dexamethasone—Betamethasone—ankylosing spondylitis	0.00125	0.016	CbGdCrCtD
Decitabine—DNMT1—Betamethasone—Dexamethasone—ankylosing spondylitis	0.00125	0.016	CbGdCrCtD
Decitabine—Dyspepsia—Prednisone—ankylosing spondylitis	0.00124	0.00135	CcSEcCtD
Decitabine—Arthralgia—Methotrexate—ankylosing spondylitis	0.00123	0.00133	CcSEcCtD
Decitabine—Myalgia—Methotrexate—ankylosing spondylitis	0.00123	0.00133	CcSEcCtD
Decitabine—Chest pain—Methotrexate—ankylosing spondylitis	0.00123	0.00133	CcSEcCtD
Decitabine—Decreased appetite—Prednisone—ankylosing spondylitis	0.00123	0.00133	CcSEcCtD
Decitabine—DNMT1—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.00122	0.0156	CbGdCrCtD
Decitabine—DNMT1—Betamethasone—Triamcinolone—ankylosing spondylitis	0.00122	0.0156	CbGdCrCtD
Decitabine—Rash—Prednisolone—ankylosing spondylitis	0.00122	0.00133	CcSEcCtD
Decitabine—Dermatitis—Prednisolone—ankylosing spondylitis	0.00122	0.00133	CcSEcCtD
Decitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00122	0.00132	CcSEcCtD
Decitabine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00122	0.00132	CcSEcCtD
Decitabine—Fatigue—Prednisone—ankylosing spondylitis	0.00121	0.00132	CcSEcCtD
Decitabine—Headache—Prednisolone—ankylosing spondylitis	0.00121	0.00132	CcSEcCtD
Decitabine—Discomfort—Methotrexate—ankylosing spondylitis	0.00121	0.00132	CcSEcCtD
Decitabine—Constipation—Prednisone—ankylosing spondylitis	0.00121	0.00131	CcSEcCtD
Decitabine—DCK—Desoximetasone—Methylprednisolone—ankylosing spondylitis	0.0012	0.0153	CbGdCrCtD
Decitabine—Confusional state—Methotrexate—ankylosing spondylitis	0.00119	0.00129	CcSEcCtD
Decitabine—DCK—Desoximetasone—Dexamethasone—ankylosing spondylitis	0.00118	0.0151	CbGdCrCtD
Decitabine—DCK—Desoximetasone—Betamethasone—ankylosing spondylitis	0.00118	0.0151	CbGdCrCtD
Decitabine—Dizziness—Triamcinolone—ankylosing spondylitis	0.00118	0.00128	CcSEcCtD
Decitabine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00118	0.00128	CcSEcCtD
Decitabine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00118	0.00128	CcSEcCtD
Decitabine—Infection—Methotrexate—ankylosing spondylitis	0.00117	0.00127	CcSEcCtD
Decitabine—DCK—Diflorasone—Methylprednisolone—ankylosing spondylitis	0.00117	0.0149	CbGdCrCtD
Decitabine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00116	0.00126	CcSEcCtD
Decitabine—Asthenia—Dexamethasone—ankylosing spondylitis	0.00116	0.00126	CcSEcCtD
Decitabine—Asthenia—Betamethasone—ankylosing spondylitis	0.00116	0.00126	CcSEcCtD
Decitabine—DNMT1—Dexamethasone—Prednisone—ankylosing spondylitis	0.00116	0.0148	CbGdCrCtD
Decitabine—DNMT1—Betamethasone—Prednisone—ankylosing spondylitis	0.00116	0.0148	CbGdCrCtD
Decitabine—DCK—Desoximetasone—Triamcinolone—ankylosing spondylitis	0.00116	0.0147	CbGdCrCtD
Decitabine—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00115	0.00125	CcSEcCtD
Decitabine—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00115	0.00125	CcSEcCtD
Decitabine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00115	0.00125	CcSEcCtD
Decitabine—Nausea—Prednisolone—ankylosing spondylitis	0.00115	0.00125	CcSEcCtD
Decitabine—DCK—Diflorasone—Dexamethasone—ankylosing spondylitis	0.00115	0.0146	CbGdCrCtD
Decitabine—DCK—Diflorasone—Betamethasone—ankylosing spondylitis	0.00115	0.0146	CbGdCrCtD
Decitabine—Pruritus—Dexamethasone—ankylosing spondylitis	0.00114	0.00124	CcSEcCtD
Decitabine—Pruritus—Betamethasone—ankylosing spondylitis	0.00114	0.00124	CcSEcCtD
Decitabine—Skin disorder—Methotrexate—ankylosing spondylitis	0.00114	0.00124	CcSEcCtD
Decitabine—Vomiting—Triamcinolone—ankylosing spondylitis	0.00113	0.00123	CcSEcCtD
Decitabine—DNMT1—Dexamethasone—Prednisolone—ankylosing spondylitis	0.00113	0.0144	CbGdCrCtD
Decitabine—DNMT1—Betamethasone—Prednisolone—ankylosing spondylitis	0.00113	0.0144	CbGdCrCtD
Decitabine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00113	0.00123	CcSEcCtD
Decitabine—Rash—Triamcinolone—ankylosing spondylitis	0.00112	0.00122	CcSEcCtD
Decitabine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00112	0.00122	CcSEcCtD
Decitabine—Anorexia—Methotrexate—ankylosing spondylitis	0.00112	0.00122	CcSEcCtD
Decitabine—Rash—Methylprednisolone—ankylosing spondylitis	0.00112	0.00122	CcSEcCtD
Decitabine—DCK—Diflorasone—Triamcinolone—ankylosing spondylitis	0.00112	0.0143	CbGdCrCtD
Decitabine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00112	0.00122	CcSEcCtD
Decitabine—Urticaria—Prednisone—ankylosing spondylitis	0.00112	0.00121	CcSEcCtD
Decitabine—Headache—Triamcinolone—ankylosing spondylitis	0.00112	0.00121	CcSEcCtD
Decitabine—Headache—Methylprednisolone—ankylosing spondylitis	0.00111	0.00121	CcSEcCtD
Decitabine—Abdominal pain—Prednisone—ankylosing spondylitis	0.00111	0.00121	CcSEcCtD
Decitabine—Body temperature increased—Prednisone—ankylosing spondylitis	0.00111	0.00121	CcSEcCtD
Decitabine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00111	0.0012	CcSEcCtD
Decitabine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00111	0.0012	CcSEcCtD
Decitabine—Hypotension—Methotrexate—ankylosing spondylitis	0.0011	0.00119	CcSEcCtD
Decitabine—DCK—Desoximetasone—Prednisone—ankylosing spondylitis	0.0011	0.014	CbGdCrCtD
Decitabine—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.00107	0.00116	CcSEcCtD
Decitabine—DCK—Desoximetasone—Prednisolone—ankylosing spondylitis	0.00107	0.0137	CbGdCrCtD
Decitabine—Dizziness—Dexamethasone—ankylosing spondylitis	0.00107	0.00116	CcSEcCtD
Decitabine—Dizziness—Betamethasone—ankylosing spondylitis	0.00107	0.00116	CcSEcCtD
Decitabine—Insomnia—Methotrexate—ankylosing spondylitis	0.00107	0.00116	CcSEcCtD
Decitabine—DCK—Diflorasone—Prednisone—ankylosing spondylitis	0.00106	0.0136	CbGdCrCtD
Decitabine—Nausea—Triamcinolone—ankylosing spondylitis	0.00106	0.00115	CcSEcCtD
Decitabine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00106	0.00115	CcSEcCtD
Decitabine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00105	0.00114	CcSEcCtD
Decitabine—DCK—Diflorasone—Prednisolone—ankylosing spondylitis	0.00104	0.0133	CbGdCrCtD
Decitabine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00104	0.00113	CcSEcCtD
Decitabine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00104	0.00112	CcSEcCtD
Decitabine—Vomiting—Betamethasone—ankylosing spondylitis	0.00103	0.00112	CcSEcCtD
Decitabine—Vomiting—Dexamethasone—ankylosing spondylitis	0.00103	0.00112	CcSEcCtD
Decitabine—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00102	0.00111	CcSEcCtD
Decitabine—Rash—Dexamethasone—ankylosing spondylitis	0.00102	0.00111	CcSEcCtD
Decitabine—Rash—Betamethasone—ankylosing spondylitis	0.00102	0.00111	CcSEcCtD
Decitabine—Dermatitis—Betamethasone—ankylosing spondylitis	0.00102	0.00111	CcSEcCtD
Decitabine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00102	0.00111	CcSEcCtD
Decitabine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00102	0.0011	CcSEcCtD
Decitabine—Fatigue—Methotrexate—ankylosing spondylitis	0.00102	0.0011	CcSEcCtD
Decitabine—Headache—Dexamethasone—ankylosing spondylitis	0.00101	0.0011	CcSEcCtD
Decitabine—Headache—Betamethasone—ankylosing spondylitis	0.00101	0.0011	CcSEcCtD
Decitabine—Asthenia—Prednisone—ankylosing spondylitis	0.00101	0.0011	CcSEcCtD
Decitabine—Pain—Methotrexate—ankylosing spondylitis	0.00101	0.00109	CcSEcCtD
Decitabine—Pruritus—Prednisone—ankylosing spondylitis	0.000997	0.00108	CcSEcCtD
Decitabine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000971	0.00105	CcSEcCtD
Decitabine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000964	0.00105	CcSEcCtD
Decitabine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000963	0.00104	CcSEcCtD
Decitabine—Nausea—Betamethasone—ankylosing spondylitis	0.000961	0.00104	CcSEcCtD
Decitabine—Nausea—Dexamethasone—ankylosing spondylitis	0.000961	0.00104	CcSEcCtD
Decitabine—Urticaria—Methotrexate—ankylosing spondylitis	0.000936	0.00102	CcSEcCtD
Decitabine—Dizziness—Prednisone—ankylosing spondylitis	0.000932	0.00101	CcSEcCtD
Decitabine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.000931	0.00101	CcSEcCtD
Decitabine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000931	0.00101	CcSEcCtD
Decitabine—Vomiting—Prednisone—ankylosing spondylitis	0.000896	0.000972	CcSEcCtD
Decitabine—Rash—Prednisone—ankylosing spondylitis	0.000889	0.000964	CcSEcCtD
Decitabine—Dermatitis—Prednisone—ankylosing spondylitis	0.000888	0.000963	CcSEcCtD
Decitabine—Headache—Prednisone—ankylosing spondylitis	0.000883	0.000958	CcSEcCtD
Decitabine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000868	0.000942	CcSEcCtD
Decitabine—Asthenia—Methotrexate—ankylosing spondylitis	0.000845	0.000917	CcSEcCtD
Decitabine—Nausea—Prednisone—ankylosing spondylitis	0.000837	0.000908	CcSEcCtD
Decitabine—Pruritus—Methotrexate—ankylosing spondylitis	0.000833	0.000904	CcSEcCtD
Decitabine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000806	0.000874	CcSEcCtD
Decitabine—Dizziness—Methotrexate—ankylosing spondylitis	0.000779	0.000845	CcSEcCtD
Decitabine—Vomiting—Methotrexate—ankylosing spondylitis	0.000749	0.000813	CcSEcCtD
Decitabine—Rash—Methotrexate—ankylosing spondylitis	0.000743	0.000806	CcSEcCtD
Decitabine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000742	0.000805	CcSEcCtD
Decitabine—Headache—Methotrexate—ankylosing spondylitis	0.000738	0.000801	CcSEcCtD
Decitabine—Nausea—Methotrexate—ankylosing spondylitis	0.0007	0.000759	CcSEcCtD
